Editors' Pick Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, et al. N Engl J Med. 2012 Sep 20; 367(12):1098-107. Epub 1969 Dec 31. PMID: 22992073. Abstract CommentRecommendBookmarkWatch